103 related articles for article (PubMed ID: 19243758)
1. Oligo-ovulation or anovulation and hyperandrogenemia contribute to the decreased serum adiponectin levels in normal-weight women with PCOS with obesity and insulin resistance.
Katsikis I; Mouslech T; Kourtis A; Panidis D; Georgopoulos NA
Fertil Steril; 2009 Apr; 91(4):e3; author reply e4. PubMed ID: 19243758
[No Abstract] [Full Text] [Related]
2. Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Kuglin D; Dąbkowska-Huć A; Skałba P
Eur J Obstet Gynecol Reprod Biol; 2011 Jan; 154(1):51-6. PubMed ID: 20889251
[TBL] [Abstract][Full Text] [Related]
3. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome.
Carmina E; Bucchieri S; Mansueto P; Rini G; Ferin M; Lobo RA
Fertil Steril; 2009 Apr; 91(4 Suppl):1332-5. PubMed ID: 18455165
[TBL] [Abstract][Full Text] [Related]
5. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
Sepilian V; Nagamani M
J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
[TBL] [Abstract][Full Text] [Related]
8. Decreased adiponectin levels in polycystic ovary syndrome, independent of body mass index.
Sharifi F; Hajihosseini R; Mazloomi S; Amirmogaddami H; Nazem H
Metab Syndr Relat Disord; 2010 Feb; 8(1):47-52. PubMed ID: 19929617
[TBL] [Abstract][Full Text] [Related]
9. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
[TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
[TBL] [Abstract][Full Text] [Related]
11. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
Yang XF; Ren FR; Guo SP
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
[TBL] [Abstract][Full Text] [Related]
12. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome.
Nafiye Y; Sevtap K; Muammer D; Emre O; Senol K; Leyla M
Fertil Steril; 2010 Apr; 93(6):1864-9. PubMed ID: 19171332
[TBL] [Abstract][Full Text] [Related]
13. The influence of obesity on androstenedione to testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia.
Misichronis G; Georgopoulos NA; Marioli DJ; Armeni AK; Katsikis I; Piouka AD; Saltamavros AD; Roupas ND; Panidis D
Gynecol Endocrinol; 2012 Apr; 28(4):249-52. PubMed ID: 21970600
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
[TBL] [Abstract][Full Text] [Related]
15. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS.
Fan P; Liu H; Wang Y; Zhang F; Bai H
Reprod Biomed Online; 2012 Feb; 24(2):197-205. PubMed ID: 22197603
[TBL] [Abstract][Full Text] [Related]
17. Adipocytokine profiles in a putative novel postmenopausal polycystic ovary syndrome (PCOS) phenotype parallel those in premenopausal PCOS: the Rancho Bernardo Study.
Krentz AJ; von Mühlen D; Barrett-Connor E
Metabolism; 2012 Sep; 61(9):1238-41. PubMed ID: 22560129
[TBL] [Abstract][Full Text] [Related]
18. Serum adiponectin levels in high school girls with polycystic ovary syndrome and hyperandrogenism.
Yasar L; Ekin M; Gedikbasi A; Erturk AD; Savan K; Ozdemir A; Temur M
J Pediatr Adolesc Gynecol; 2011 Apr; 24(2):90-3. PubMed ID: 21190873
[TBL] [Abstract][Full Text] [Related]
19. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone secretion and insulin-like growth factor-1 are related to hyperandrogenism in nonobese patients with polycystic ovary syndrome.
Premoli AC; Santana LF; Ferriani RA; Moura MD; De Sá MF; Reis RM
Fertil Steril; 2005 Jun; 83(6):1852-5. PubMed ID: 15950665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
